Dr. Melo is graduated in Biological Sciences from the University of Campinas (1990), Master and PhD in Biological Sciences from the University of Campinas in 1994 and 1998, respectively. During her PhD, she was a fellow at the Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA. From 2001 to 2007 she was professor at the Faculty of Medical Sciences, Santa Casa de São Paulo and is currently a researcher at the Center of Molecular Biology and Genetic Engineering (CBMEG - UNICAMP). Dr. Melo has research experience in the area of Human and Medical Genetics, specially on the following themes: genetics in hematology and ophthalmology. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The purpose of this project is to manage the portion of the Technical Reserve for Institutional Infrastructure Costs for Research for the year 2021, aiming at improving the common use infrastructure of CBMEG, adapt the FEQ area to receive the EMU project, as well as carry out equipment maintenance both in CBMEG and FEQ. (AU)
The purpose of this project is to manage the portion of the Technical Reserve for Institutional Infrastructure Costs for Research for the Year 2020, aiming at improving the common use infrastructure of CBMEG, as well as performing equipment maintenance. (AU)
The proposed Thematic Project "Pathophysiological Mechanisms and Treatment of Red Blood Cell Abnormalities" will be developed by the Red Blood Cell Research Group at the Hematology Center, the Department of Clinical Pathology and the Center for Molecular Biology and Genetic Engineering (CBMEG), UNICAMP, in collaboration with various Brazilian and international researchers. The project aim…
(Only some records are available in English at this moment)
This new Multi-PI thematic project proposal will be conducted by the Red Blood Cell Research Group, which is formed by researchers from the Hemocentro (Blood Center), the Department of Clinical Pathology, School of Medical Sciences and the Molecular Biology and Genetic Engineering Center (CBMEG) at UNICAMP, in collaboration with several Brazilian and international researchers. The new pro…
Among the ophthalmological complications present in sickle cell disease, retinal changes are the most relevant with regard to ocular morbidity. Proliferative sickle cell retinopathy (PSCR) occurs due to vaso-occlusion of the ocular microvasculature, which may lead to neovascularization in its proliferative form, which eventually unfolds into vitreous hemorrhage and detachment of the retin…
Ophthalmologic complications are frequent in Sickle Cell Disease and include conjunctival abnormalities, Orbital Infarcts, Retinopathy, and Retinal Hemorrhage. Retinal alterations are the most important for eye morbidity in Sickle Cell Diseases, especially its proliferative form, which is the major cause of progressive loss of vision in these patients, leading to visual impairment in 10 t…
Sickle cell anemia (SCA) is a hemoglobinopathy resulting from a homozygous mutation in the seventh codon of the beta-globin gene. However, there is extensive clinical variability, with systemic involvement. Neurological changes are common, and it has been related to the greater severity of the disease, being fatal in 15% of cases. Transient ischemic accidents, infarctions and cerebral hem…
(Only some records are available in English at this moment)
Glaucoma is a neurodegenerative disease of multifactorial etiology that includes several eye disorders whose common features are the progressive damage of the optic nerve with vision loss. It is a major cause of irreversible blindness in the world. Primary open angle glaucoma (POAG) is the most common type of the disease, while Juvenile Open Angle Glaucoma (JOAG) is an earlier onset and m…
Although sickle cell anemia (SCA) results from the homozygosity of a single mutation in amino acid 6 of the ²-globin locus, this disease presents high phenotypic heterogeneity, so that different patients may have significantly different clinical outcomes. Vascular occlusion occurs systemically, and transient ischemic attacks, stroke and cerebral hemorrhage affect approximately 25% of pati…
| 4 / 4 | Ongoing research grants |
| 5 / 3 | Completed research grants |
| 3 / 3 | Ongoing scholarships in Brazil |
| 22 / 13 | Completed scholarships in Brazil |
| 2 / 2 | Completed scholarships abroad |
| 36 / 25 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID